✦ LIBER ✦

Double-Unit Cord Blood Transplantation after Myeloablative Conditioning for Patients with Hematologic Malignancies: A Multicenter Phase II Study in Japan

✍ Scribed by Kai, Shunro; Wake, Atsushi; Okada, Masaya; Kurata, Mio; Atsuta, Yoshiko; Ishikawa, Jun; Nakamae, Hirohisa; Aotsuka, Nobuyuki; Kasai, Masaharu; Misawa, Mahito; Taniguchi, Shuichi; Kato, Shunichi

Book ID: 122059219
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 353 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.02.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective Multicenter Study of Single-

Prospective Multicenter Study of Single-Unit Cord Blood Transplantation with Myeloablative Conditioning for Adult Patients with High-Risk Hematologic Malignancies

✍ Mori, Takehiko; Tanaka, Masatsugu; Kobayashi, Takeshi; Ohashi, Kazuteru; Fujisaw 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Unrelated cord blood transplantation aft

✍ Yasuhiro Ebihara; Satoshi Takahashi; Shinji Mochizuki; Seiko Kato; Toshiro Kawak 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Phase II Trial of Non-Myeloablative Cond

Phase II Trial of Non-Myeloablative Conditioning (NST) Double Umbilical Cord Blood Transplantation (DUCBT) From Unrelated Donors in Patients With Hematologic Malignancies: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0604

✍ C.G. Brunstein; S. Carter; E.J. Fuchs; C. Karanes; S. Devine; O. Aljitawi; C. Cu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Comparative single-institute analysis of

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen

✍ Takahashi, S.; Ooi, J.; Tomonari, A.; Konuma, T.; Tsukada, N.; Oiwa-Monna, M.; F 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 228 KB

Phase I-II Study of Clofarabine-Melphala

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Advanced Hematologic Malignancies: Unexpected Renal Toxicity

✍ K. van Besien; J. Kline; L. Godley; R.A. Larson; O. Odenike; E.S. Rich; W. Stock 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Unrelated stem cell transplantation afte

✍ Nicolaus Kröger; Avichai Shimoni; Georgia Schilling; Rainer Schwerdtfeger; Marti 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB